glp-1 drug makers Market Overview: Agonists and the Obesity Market | Blog Market Overview: GLP-1 Agonists and

People using these medicines can lose more weight than with diet and exercise alone a loss of between 5% and 21% of their body weight can be expected depending on which medicine is taken and how long it is used

and is not a GLP-1 agonist drug.**

22, 2025, when the U.S Food and Drug Administration (FDA) approved oral Wegovy by Novo Nordisk as the first daily, oral GLP-1 pill for weight management.

Zepbound (tirzepatide) is FDA approved weight loss medication for adults with obesity

Injecting GLP-1 medications like Ozempic, Wegovy, or Mounjaro may seem daunting at first but once you understand the process, it becomes a simple part of your health routine